Novel Biopolymer for Targeted Drug Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 2108
Special Issue Editors
Interests: physicochemical and biological properties of water-soluble biopolymers derived from biomass (e.g., plants, seaweeds, and bacteria) and food waste; development of soft nanostructured biomaterials obtained by physical, chemical or enzymatic methods (e.g., hydrogels, polyelectrolyte complexes, colloidal micro- and nanoparticles, and emulsions); mechanistic aspects of interaction of these biomaterials with biological systems (epithelia, mucosa, bacteria, and biofilms); colloidal nanoparticles for drug and gene delivery and for antibacterial targeting; association and release of bioactive compounds relevant to food and pharmacy
Special Issues, Collections and Topics in MDPI journals
Interests: drug; drug delivery; biological samples; sample treatment; targeted therapy; liquid chromatography; mass spectrometry; supramolecular solvents; antioxydants
Special Issue Information
Dear Colleagues,
Smart drug delivery biosystems with performed therapeutic efficacy within optimal patient compliance and cost effectiveness have been explored. Biodegradable polymers have been widely employed in the clinical delivery industry because they can be biologically broken down inside the human body, releasing non-toxic components. Tailored biocompatible drug delivery benefits from a comprehensive understanding of biopolymers features, which involve extraction manufacturing techniques, chemistry, and studies of surface properties, rheology, and biodegradability.
This Special Issue will focus on “Novel Biopolymer for Targeted Drug Therapy”. Original research papers and comprehensive reviews are welcomed.
Prof. Dr. Francisco M. Goycoolea
Dr. Francesca Accioni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biopolymer
- targeted therapy
- biomaterials
- bioactivity
- microparticles
- nanoparticles
- nanocomposites
- hydrogel
- drug delivery
